RT Book, Section
A1 Ciccone, Charles D.
A2 DeTurk, William E.
A2 Cahalin, Lawrence P.
SR Print(0)
ID 6874263
T1 Chapter 8. Medications
T2 Cardiovascular and Pulmonary Physical Therapy: An Evidence-Based Approach, 2e
YR 2011
FD 2011
PB The McGraw-Hill Companies
PP New York, NY
SN 978-0-07-159814-9
LK accessphysiotherapy.mhmedical.com/content.aspx?aid=6874263
RD 2024/04/24
AB Medications  play  an  integral  role  in  the  treatment  of  patients  with  cardiovascular  and  pulmonary  disorders.  Drugs  can  be  used  to  prevent  or  treat  various  pathologies  and  impairments  in  the  heart,  lungs,  and  circulation,  and  thereby  reduce  the  functional  limitations  and  disability  associated  with  cardiopulmonary  disease.  Medications  can  likewise  have  a  synergistic  effect  with  physical  therapy  interventions.  Drugs,  for  example,  that  improve  cardiac  pumping  ability,  may  enable  patients  to  participate  more  effectively  in  interventions  that  improve  aerobic  capacity  and  endurance.  All  medications  likewise  produce  side  effects  that  can  have  a  direct  impact  on  physical  therapy  interventions.  For  instance,  drugs  that  lower  blood  pressure  (antihypertensives)  may  produce  dizziness  and  incoordination  if  they  cause  excessive  hypotension.  It,  therefore,  makes  sense  that  physical  therapists  have  a  basic  understanding  of  the  common  cardiovascular  and  pulmonary  medications  and  how  these  medications  can  affect  patients  receiving  physical  therapy.